An analysis of comparative trails of L-asparaginase (NSC-109929), cyclophosphamide and placebo in patients with inoperable bronchogenic carcinoma using corrected survival estimates

Oncology. 1978;35(1):33-8. doi: 10.1159/000225252.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Asparaginase / administration & dosage
  • Asparaginase / adverse effects
  • Asparaginase / therapeutic use*
  • Carcinoma, Bronchogenic / drug therapy*
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Placebos

Substances

  • Placebos
  • Cyclophosphamide
  • Asparaginase